Introduction {#Sec1}
============

Recently, nanotechnology has been a subject of great interest, offering considerable advantages in many areas. Titanium dioxide (TiO~2~ NPs) is among the most often used nanoparticles. The particle size depends on its application, including ultrafine particles \< 100 nm, and fine particles 0.1 to ca. 3 μm \[[@CR1]\]. It occurs in three different variants: as rutile, anatase and, more rarely, brookite \[[@CR2], [@CR3]\] (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR4]\]. With regard to its increased photocatalytic activity \[[@CR3], [@CR5]\], anatase in comparison to rutile and brookite has a higher number of industrial applications; however, it is the most toxic form \[[@CR6]\].Fig. 1Tetragonal structures of crystalline forms of rutile, anatase and brookite TiO~2~ NPs (spheres: red---0~2~, grey---Ti). Based on Samat et al. \[[@CR4]\]

Occurrence of TiO~2~ NPs {#Sec2}
========================

TiO~2~ NPs is used in many areas of life, such as environmental protection and building engineering, medicine, agriculture and the food and cosmetic industry \[[@CR4]\] (Fig. [2](#Fig2){ref-type="fig"}) \[[@CR7]\]. With regard to its catalytic properties, TiO~2~ NPs are a component of self-cleaning roof tiles, windows, they are used in water and sewage treatment, gas combustion, as an antibacterial material for decontamination, as well as a catalyst in organic synthesis \[[@CR2], [@CR8]\]. Their biomedical applications include pharmaceuticals and medical devices \[[@CR2]\]. In the agriculture industry, they are used in the production of fertilisers and pesticides which can significantly affect soil fertility, growth of plants and crop yield \[[@CR9], [@CR10]\]. TiO~2~ NPs have a wide range of applications in the food industry (E171) \[[@CR11], [@CR12]\]; they are used in the processing and packing of food for the purposes of product improvement. They are also used in the cosmetics industry, pharmaceuticals and toothpastes \[[@CR13]--[@CR15]\]. They have a wide-range antibacterial effect extending the shelf life of foodstuffs \[[@CR16], [@CR17]\]*.*Fig. 2Application of TiO~2~ NPs (%) in industry. Based on Hong et.al \[[@CR7]\]

With regard to the fact that TiO~2~ NPs are used widely and commonly in many areas of industry, the risk of exposure increases; hence, their potential effect on the human body should be explored in more detail.

TiO~2~ NPs in Foodstuffs {#Sec3}
========================

In recent years, the effect of nanoparticles on human health has given rise to serious controversies. According to the Nanotechnology Consumer Product Inventory (CPI), from March 2015, the global market offered 1814 products based on nanotechnology, including 117 in the "food and beverage" category \[[@CR18], [@CR19]\]. In the USA, TiO~2~ NPs can be used in food if its content does not exceed 1% of the total weight of the product containing nTiO~2~ \[[@CR20]--[@CR22]\]. In Europe, the *at quantum satis* principle is in force, which means it can be used in amounts not exceeding the intended target level \[[@CR23], [@CR24]\].

TiO~2~ NPs as a Food Additive {#Sec4}
=============================

TiO2 NPs are added to many foodstuffs, including cheeses and sauces, skimmed milk, ice cream and confectionery products, e.g. as coating on sweets and chewing gum \[[@CR23], [@CR25]--[@CR27]\]. Its content in sweets, and in particular in candy, chewing gum, chocolate and white-coated products, compared to other products, is very high, reaching 2.5 mg Ti/g of food \[[@CR24], [@CR25]\]. It is estimated that a child can consume even 2--4 times more TiO~2~ NPs per 1 kg of body weight (bw) a day than an adult person. In Great Britain, children under the age of 10 consume about 2--3 mg TiO~2~/kg BW/day, while adults consume about 1 mg TiO~2~/kg bw/day \[[@CR6]\].

Safety of TiO~2~ NPs in Foodstuffs {#Sec5}
==================================

The wide applications of TiO~2~ NPs in the food industry give rise to many controversies regarding safety. The International Agency for Research on Cancer (IARC) classified the TiO~2~ NPs pigment as a potential carcinogenic factor from group 2B (probably carcinogenic to humans) based on mechanisms and tests involving animals regarding exposure by inhalation \[[@CR28]--[@CR30]\]. The European Food Safety Authority (EFSA) in its latest study on the safety of E171 (titanium dioxide) in 2016 found that data concerning values and exposure of humans to TiO~2~ NPs in food do not raise concerns \[[@CR24]\]. However, with regard to the insufficiency of research data, the admissible daily intake of TiO~2~ NPs was not determined. Based on the results of tests involving animals, a safety margin of 2.25 mg TiO~2~ NPs/kg bw/day was established \[[@CR24]\].

Ways of Exposure and Accumulation of TiO~2~ NPs in Human/Animal Body {#Sec6}
====================================================================

The effect of TiO~2~ NPs on the human body has been explored for many years. Both its exposure and toxicity to a human body/animal body has been widely investigated and discussed. The crystalline structure, particle size and coating can affect the surface charge, sedimentation, aggregation and thus toxicity of TiO~2~ NPs \[[@CR31]--[@CR34]\].

The previous in vitro and in vivo tests confirm the toxic effects of TiO~2~ NPs on human body such as altered cell cycle, constriction of nuclear membranes and apoptosis \[[@CR35]--[@CR38]\]. Studies also showed that TiO~2~ NPs can cause DNA damage \[[@CR32], [@CR39], [@CR40]\] and interact with the epithelium of the small intestine responsible for absorption of nutrients. After exposure to TiO~2~ NPs by *various* ways, mainly by inhalation, injection, skin contact and absorption in the alimentary tract, TiO~2~ NPs can be found in different internal organs. In vivo tests revealed that after inhalation or oral exposure, TiO~2~ NPs accumulate in, among other places, the lungs, alimentary tract, liver, heart, spleen, kidneys and cardiac muscle. In addition, they disturb glucose and lipid homeostasis in mice and rats \[[@CR41]--[@CR43], [@CR34]\]. Age can also be a factor playing a significant role in the harmful effect of TiO~2~ NPs. As indicated by the results of tests on young and adult rats \[[@CR44]\], different age groups can require different biomarkers for detecting and monitoring oral toxicity of nanoparticles. In young rats, liver swelling was observed, along with cardiac injuries and non-allergic activation of mast cells in gastric tissue. On the other hand, adult animals showed insignificant liver and renal damage as well as reduced intestinal permeability and molybdenum content following exposure to TiO~2~ NPs. Wang et al. \[[@CR45]\] demonstrated that the size of nanoparticles can affect both toxicity and accumulation of TiO2 NPs in different organs. Those authors, after a one-time oral administration of TiO~2~ NPs to mice of different size, demonstrated that larger particles (80 nm) are mainly accumulated in the liver, whereas smaller particles (25 nm) can be found in the spleen and, to a lesser extent, in the kidneys and lungs.

Biodistribution and Absorption of TiO~2~ NPs in Human/Animal Body {#Sec7}
=================================================================

All nanomaterials can differ considerably in composition, charge, morphology, specific surface area and state of matter, which has an influence on what happens to them in the alimentary tract and potential toxicity \[[@CR46]\]. Food differs greatly in terms of its composition, appearance, structure and physical properties, which can lead to perceptible changes in the properties of nanoparticles, including their release, transport, solubility, state of matter and absorption. The nature and type of food containing inorganic nanoparticles can affect what happens to them in the alimentary tract \[[@CR46], [@CR47]\]. The content of water can affect the release of nanoparticles from the food matrix, whereas processing of food before it is swallowed can significantly alter the structure and properties of proteins \[[@CR47], [@CR48]\]. NPs, before they are absorbed in the human body, must pass through the gastrointestinal tract (GIT) regions (Fig. [2](#Fig2){ref-type="fig"}), which can alter their properties and change their potential toxicity \[[@CR47]\]. The degree of intake and absorption of TiO~2~ NPs from the GIT into the blood circulation system can depend on many factors, i.e. species, type of particles/nanoparticles, their size, dispersability or particle charging \[[@CR49], [@CR50]\].

The current data is inconsistent and most of it indicates that when swallowed, most particles are not absorbed into the blood circulation system but are excreted with the GIT \[[@CR49]\]. The results of recent studies showed that TiO~2~NPs were scarcely captured from the GIT and transferred into systemic circulation in rats and humans \[[@CR51]--[@CR53]\]. Studies concerning toxicity after oral administration to rats show a low level of toxicity at NOAEL \> 1000 mg/kg bw/24 h (NOAEL---no observable adverse effect level) \[[@CR49]\]. Cho et al. \[[@CR53]\] demonstrated that the concentration of titanium in blood, when TiO~2~ NPs were administered to rats as particles every day (up to 1042 mg/kg bw/day), was not significantly higher than in the control group. Similarly, MacNicoll et al. \[[@CR54]\] in their studies involving rats showed that a dose of 5 mg TiO~2~ NPs/kg body weight did not lead to considerable capturing of TiO~2~ NPs (measured as titanium) from the GIT into the blood, urine or different internal organs. Also, studies involving humans found that the absorption from the GIT into blood and urine was scarce \[[@CR51]\]. It was demonstrated that both after administration of a single dose to volunteers (5 mg/kg bw/day) and of TiO~2~ NPs with different particle sizes, 15 nm (nanoshell), 100 nm (nanoshell) and \< 5000 nm (pigments), TiO~2~ NPs had no impact on increased absorption of titanium depending on the particle size \[[@CR51]\].

Alimentary Tract {#Sec8}
================

Studies have shown that nanoparticles can disturb digestion and absorption of food components, which can lead to deficiencies of macro- and microelements in the body \[[@CR47]\]. Chen et al. \[[@CR55]\] studied the toxicity of TiO~2~ NPs in mice in vivo. Different doses (0, 324, 648, 972, 1296, 1944, 2592 mg/kg) were injected into their mouth at different time intervals (24 h, 48 h, 7 days and 14 days). Mice showed strong symptoms of toxicity (loss of appetite, passive behaviour, trembling and lethargy). The highest accumulation of TiO~2~ NPs was found in the spleen that also sustained damage. Other observations included necrosis of liver cells and apoptosis, liver fibrosis and swelling of renal glomeruli. TiO~2~ NPs were also deposited in the lungs where blood clots were found that could have resulted from blockage of blood vessels. Duan et al. \[[@CR56]\] demonstrated weight loss in mice after intragastric administration of TiO~2~ NPs anatase in doses of 125 and 250 mg/kg. This should be explained by the reduced number of intestinal villi and the resulting loss of surface of the small intestine capable of absorbing nutrients, which consequently leads to malnutrition and weight loss. Amedollia et al. \[[@CR57]\] in their studies also showed that after oral exposure of rats to a dose of 2 mg/kg body weight, TiO~2~ NPs are capable of penetrating the intestinal mucosa. Brun et al. \[[@CR58]\] argue that it is likely that TiO~2~ NPs would be translocated both through the ileac epithelium and through Peyer's patches, which would lead to damage and most likely chronic failure of the intestinal epithelium. Nogueira et al. \[[@CR59]\] found an inflammation in the small intestine of mice after they were administered TiO~2~ NPs (66 nm) by oral gavage in the dose of 100 mg/kg over 10 days.

The results of the abovementioned in vivo tests confirmed the results of in vitro studies on human intestine cell cultures. The authors \[[@CR60]\] came to similar conclusions. Their studies on Caco-2/HT29-MTX cells showed that exposure to TiO~2~ NPs had a considerable impact on the transportation of nutrients, that is, Fe and Zn, capturing of fatty acids and IAP activity (inhibitor of apoptosis protein). They found a decrease in the number of microvilli resulting in a reduction of the surface area available for absorption of nutrients. Faust et al. \[[@CR21]\], in their in vitro studies of the human intestine model, showed that after exposure to TiO~2~ NPs, the villi in the small intestine were destroyed. They also found that about 42% of intestinal microvilli were lost when 350 ng of TiO~2~ NPs were added per 1 cm^2^ of the medium.

The present studies provide evidence that TiO~2~ NPs have both a positive and negative effect on the quality of intestinal villi, which seems to be dependent on the dose and on the age of the animals. In young animals, the permeability of the intestinal wall is probably higher, and thus the rate of absorption and bioavailability is increased, which leads to increased exposure to TiO~2~ NPs \[[@CR61]\].

Wang et al. \[[@CR62]\], after intragastric administration of TiO~2~ NPs to mice over 30 days in three doses (5, 50 and 150 mg/kg bw), observed insignificant damage to the cells of the spleen (denser and larger lymph follicles in splenic tissue) in animals exposed to the lowest dose, which was not the case with higher concentrations. TiO~2~ NPs caused a significant increase in the accumulation of reactive oxygen species in the spleen of mice due to lipid peroxidation. Mohamed \[[@CR63]\] administered 5, 50 and 500 mg TiO~2~ NPs/kg bw to mice orally and found that, even when the dose was low, TiO~2~ NPs were permanently accumulated in mice, which led to inflammation, apoptosis and oxidative stress, and consequently induced chronic gastritis.

In most of the existing studies, liver failure was observed in mice and rats exposed to TiO2 NPs. Bu et al. \[[@CR64]\], after oral administration of TiO~2~ NPs to rats, observed liver and heart damage as the consequences of disturbances in energy and amino acid metabolism and in intestinal microflora. Duan et al. \[[@CR56]\] came to similar conclusions. They observed an increase in liver ratios and histopathological changes in the liver after oral administration of TiO~2~ NPs (5 nm) to mice at 62.5, 125 and 250 mg/kg bw over 30 days.

In three publications, the researchers \[Kreyling et al. [@CR65]--[@CR67]\] investigated biokinetics and translocation of TiO~2~ NPs administered via three classical ways (intravenous injection (40--400 mg/kg), oral administration (30--80 mg/kg) and injection into the trachea (40--240 mg/kg) in identical laboratory conditions. Female rats were administered single doses of anatase nanoparticles (TiO~2~ NPs) 48V isotope labelled to ensure precise tracking of translocation kinetics and total biodistribution of 48V-nTiO~2~ NPs in different tissues over 28 test days. It was found that a single dose administered orally was 99.7% excreted with faeces whereas 0.3% remained in the body for at least 7 days and continued to accumulate in the liver and spleen according to previous studies \[[@CR68], [@CR44], [@CR45]\]. Other results of tests on mice show that oral administration of 5 mg TiO~2~ NPs/kg bw (5 days, 10 weeks) can contribute to intensification of an existing intestinal cancer (colon cancer) \[[@CR69]\].

Literature also recounts cases where TiO~2~ NPs had no toxic effect. In the 90-day-long study on oral toxicity, male and female rats were exposed to TiO~2~ NPs via gastric tube at 0, 100, 300 and 1000 mg/kg bw/day. No deaths were recorded in connection with TiO~2~ NPs and no clinical, ophthalmological or neurobehavioural changes were observed due to exposure to TiO~2~ NPs. In addition, no adverse effects on body weight were recorded. The largest examined dose, i.e. 1000 mg/kg BW/day, did not cause any changes in male and female rats \[[@CR49]\].

Similarly, Warheit et al. \[[@CR70]\] did not find any changes in the body weight of rats after administration of 5 g TiO~2~ NPs/kg BW. Other authors \[[@CR57]\] studying HT-29 cell cultures did not find TiO~2~ NPs to have a cytotoxic effect at different concentrations (1--20 mg/cm^2^) after 6, 24 and 48 h exposure, either. Table [1](#Tab1){ref-type="table"} summarises the effect of TiO~2~ NPs exposure.Table 1The effect of exposure to NPsTiO~2~ on the alimentary tractModelType NPsTiO~2~DoseExposure timeEffectReferencesMiceAnatase-TiO~2~0.324, 648, 972, 1296, 1944, 2592 mg/kg24 h, 48 h, 7, 14 daysSpleen damage, necrosis of liver cells and apoptosis, liver fibrosis, swelling of renal glomeruli\[[@CR55]\]RatsAnatase-TiO~2~2 mg/kg5 days\[[@CR57]\]Caco-2/HT29-MTXUnknown106 s/cm^2^ (low), 108/cm^2^ (medium) and 1010/cm^2^ (high)4 h, 5 daysDecrease in the number of microvilli resulting in a reduction of the surface area available for absorbtion of nutrients\[[@CR60]\]Caco-2BBe1Food gradeTiO~2~, isolated from candy350 ng TiO~2~ NPs/cm^2^ medium19--21 days\[[@CR21]\]MiceAnatase TiO~2~5, 50 and 150 mg/kg30 daysInsignificant damage to the cells of the spleen in animals exposed to the lowest dose. Significant increase in the accumulation of reactive oxygen species in the spleen of mice due to lipid peroxidation\[[@CR62]\]MiceMixture of rutile and anatase5, 50 and 500 mg/kg24 h, 7 and 14 daysApoptosis, oxidative stress, chronic gastritis\[[@CR63]\]RatsUnknown0.16, 0.4 and 1 g/kg14 daysLiver and heart damage as the consequences of disturbances in energy and amino acid metabolism and in intestinal microflora\[[@CR64]\]MiceAnatase TiO~2~62.5, 125 and 250 mg/kg30 daysAn increase in liver ratios and histopathological changes in the liver\[[@CR56]\]MiceFood-grade TiO~2~ was from SENSIENT COLOURS5 mg/kg5 sTiO~2~ NPs can contribute to intensification of an existing intestinal cancer (colon cancer)\[[@CR69]\]

Cardiovascular System {#Sec9}
=====================

Different ways of exposure to nanoparticles can have various influences on the cardiovascular system. The influence depends on the amounts, dose of exposure, mechanisms and transfer routes, duration of exposure and the target organ \[[@CR20]\].

Some studies showed that TiO~2~ NPs could be toxic and have a negative effect on the cardiovascular system. The inflammatory response triggered by TiO~2~ NPs is deemed one of the main causes for cardiovascular system malfunction. Increased expression of inflammatory cytokines such as TNF-α, INF-g and IL- 8 in blood after intake of TiO~2~ NPs was observed by Gui et al. \[[@CR71]\] and Trouiller et al. \[[@CR72]\]. Chen et al. \[[@CR20]\], in their in vivo tests on rats, set forth a hypothesis that heart damage and inflammatory response could be possible mechanisms of adverse cardiovascular activity triggered by TiO~2~ NPs. They demonstrated that a low dose of TiO~2~ NPs could lead to potential undesirable cardiovascular effects after 30 or 90 days of oral exposure. After 90 days of intravenous administration of TiO~2~ NPs (0, 2, 10, 50 mg/kg), those authors observed heart arrhythmia manifested in reduced activity of lactate dehydrogenasis (LDH), α-hydroxybutyrate dehydrogenase (alpha-HBDH) and creatine kinase (CK). After shorter exposure to TiO~2~ NPs (30 days), changes in heart rate (HR) and blood pressure (BP) could be noted. Savi et al. \[[@CR73]\] discovered that intra-breath in vivo administration of the saline solution containing TiO~2~ NPs (2 mg/kg) increased the rate of cardiac conduction, which results in increased likelihood of developing arrhythmia. Kan et al. \[[@CR74]\], in their studies, demonstrated that after inhalation of ultrafine titanium dioxide (UFTiO~2~), the heart rate considerably increased and the average diastolic blood pressure was higher in response to isoproterenol.

Wang \[[@CR45]\] evaluated the toxicity of TiO~2~ NPs (25 and 80 nm) in adult mice in comparison to fine TiO~2~ NPs (155 nm). A fixed dose of 5 g/kg bw was determined according to the procedure designed by the Organisation for Economic Cooperation and Development (OECD). Changes were identified in the following biochemical parameters in blood serum: ALT/AST, LDH (alkaline phosphatase (ALT); aspartate aminotransferase (AST); lactate dehydrogenase (LDH), which suggested liver damage after exposure to TiO~2~ NPs. In addition, nephrotoxicity and pathological renal lesions could be observed in experimental groups. Rats receiving nanoparticles 25 and 80 nm in size showed a considerable change in the activity of LDH and α-HBDH in blood serum compared to the control group, which suggested cardiac muscle damage. No pathological lesions were found in the heart, lung, testicle (or ovary) and splenic tissues***.***

Bu et al. \[[@CR64]\] observed that daily oral administration of TiO~2~ NPs (160, 400 and 1000 mg/kg) to rats over 14 days led to disturbances in energy and amino acid metabolism and in intestinal microflora. They suggested it could cause slight damage to the liver and the heart. Comparative tests of TiO~2~ NPs toxicity after 30 days of oral exposure (0, 10, 50, 200 mg/kg BW/day) to 3-week-old (adolescent) and 8-week-old (adult) rats revealed decreased activity of HBDH and CK in young rats, which points to potential damage of the cardiac muscle \[[@CR44]\] Hong et al. \[[@CR75]\] in their studies involving mice showed that 6 months of exposure to TiO~2~ NPs (1.25, 2.5 and 5 mg/kg) caused damage to the cardiac muscle and pneumonia, which could be a result of disturbed expression of cytokines connected with Th1 or Th2 in the heart of mice. Table [2](#Tab2){ref-type="table"} summarises the effect of TiO~2~ NPs exposure.Table 2The effect of exposure to NPsTiO~2~ on the cardiovascular systemModelType NPsTiO~2~DoseExposure timeEffectReferencesRatsAnatase TiO~2~0, 2, 10, 50 mg/kg30 and 90 daysHeart arrhythmia manifested in reduced activity of LDH, HBDH and CK, changes in heart rate and blood pressure\[[@CR20]\]RatsMixture of anatase and rutile2 mg/kg4 hIncreased the rate of cardiac conduction, arrhythmia\[[@CR73]\]RatsRutile UFTiO~2~Areozol 6 mg/m^3^4 hIncreased heart rate, increased diastolic blood pressure\[[@CR74]\]MiceUnknown5 g/kg14 daysConsiderable change in the activity of LDH and alpha-HBDH in blood serum, which suggested cardiac muscle damage. No pathological lesions were found in the heart, lung, testicle (or ovary) and splenic tissue\[[@CR45]\]RatsUnknown160, 400 and 1000 mg/kg14 daysDisturbances in energy and amino acid metabolism and in intestinal microflora. It could cause slight damage to the liver and the heart\[[@CR64]\]RatsAnatase TiO~2~0, 10, 50, 200mg/kg30 daysDecreased activity of HBDH (hydroxybutyrate dehydrogenase) and CK (creatine kinase), damage of the cardiac muscle\[[@CR44]\]MiceAnatase TiO~2~1.25, 2.5 and 5 mg/kgHalf a yearDamage to the cardiac muscle\[[@CR75]\]*CK* creatine kinase, *LDH* lactate dehydrogenase, α-*HBDH alpha-*hydroxybutyrate dehydrogenase), *HBDH* hydroxybutyrate dehydrogenase

Nervous System. The Brain {#Sec10}
=========================

Nanoparticles, due to their small size, are able to cross the blood-brain barrier (BBB). When inhaled, they accumulate in three different regions of the respiratory tract: the nose and pharynx, trachea and teeth and lung alveoli. From there, through sensory nerves \[[@CR76], [@CR77]\], they are accumulated mainly in the areas of the brain such as the olfactory bulb and the hippocampus \[[@CR3], [@CR78], [@CR38]\].

In the brain, TiO~2~ NPs can cause protein oxidation, oxidative damage \[[@CR3], [@CR79], [@CR29]\] and impairment of antioxidative capacity and increased production of reactive oxygen species (ROS). Other findings include shrinkage of nuclear envelopes \[[@CR38]\], apoptosis \[[@CR33]\], changes in the content of microelements and macroelements, i.e. copper (Cu), potassium (K) and zinc (Zn) \[[@CR80]\], and upset the BBB \[[@CR81]\]. According to test results, oxidative stress (OS), apoptosis and the inflammatory response are the main mechanisms underlying the neurotoxicity of metallic nanoparticles \[[@CR42]\]. Test results show that antioxidants can reverse neurotoxicity of metallic NPs by decreasing the production of ROS, increasing the activity of antioxidative enzymes, inhibiting the inflammatory condition and reducing the share of apoptotic cells \[[@CR42]\].

Many studies revealed a toxic effect of TiO~2~ NPs depending on the duration of exposure and the dose of NPs. Some authors \[[@CR76], [@CR82]\] observed this relationship in cultured murine microglia N9 cells. They found that TiO~2~ NPs could elicit apoptosis of N9 cells in vitro, and thus present a potential risk for the central nervous system (CNS). Ze et al. \[[@CR83]\] over 90 days administered TiO~2~ NPs to mice at three doses and found that NPs could translocate and accumulate in the brain. They demonstrated that the levels of the superoxide (O2^−^), H~2~O~2~, carbonyl protein, 8-hydroxy-2′-deoxyguanosine and malondialdehyde (MDA) in the brain of mice were increased in all groups compared to the control group. In addition, changes were identified in the expression of genes associated with OS in the brain of mice. Long et al. \[[@CR84]\] observed that TiO~2~ NPs stimulated brain microglia to produce ROS and disturbed the production of mitochondrial energy. Huerta-García et al. \[[@CR85]\], in their studies, found that TiO~2~ NPs had a toxic effect on the glial cells (C6 and U373P) of rats and humans. Nanoparticles induced morphological changes, damage to mitochondria and increased the mitochondrial membrane potential (MMP). Other researchers \[[@CR86]\] after exposure to TiO~2~ NPs also observed a decrease in the mitochondrial membrane potential and the levels of nicotinamide adenine dinucleotide (NADH), the mitochondrial function and the production of ROS during mitochondrial respiration in rat tissues.

Márquez-Ramírez et al. \[[@CR33]\] evaluated the effect of TiO~2~ NPs on the glial cells of humans (U373) and rats (C6). They found that, after 96 h of exposure, TiO~2~ NPs had a toxic effect on glial cells by inducing their apoptosis, which suggests that exposure to NPs can lead to brain damage. The study by Coccini et al. \[[@CR36]\] showed that TiO~2~ NPs had a neurotoxic effect on human brain lines SH-SY5Y and D384. Both after short-term (acute) exposure (4, 24, 48 h; 1.5--250 μg/ml) and long-term exposure (7--10 days; from 0.05 to 31 μg/ml) to TiO~2~ NPs, a toxic effect on the studied cell cultures was observed regardless of the dosage.

Wu et al. \[[@CR87]\] investigated the cytotoxicity of TiO~2~ NPs by means of PC12 cells (cells used as a model of dopaminergic neurons in vitro for the purposes of studies on neurodegenerative diseases). They observed apoptosis and inhibited cell cycle in PC12 cells after exposure to TiO~2~ NPs. They also noticed that nanoparticles were more toxic than micrometre particles and that anatase was more toxic than rutile. Sheng et al. \[[@CR88]\] showed that TiO~2~ NPs had a cytotoxic effect on primary hippocampal neurons in 1-day-old foetal rats. Other authors \[[@CR89]\] found that exposure to TiO~2~ NPs at two doses (0.25, 0.5 mg/ml) over 24 h resulted in decreased cell viability, increased release of lactate dehydrogenase and apoptosis. It was also demonstrated that the rate of apoptosis of neurons varied depending on the dose. In addition, TiO~2~ NPs led to an increase in \[Ca^2\ +^\] and a reduction in MMP. Those studies suggest that the apoptosis of hippocampal neurons triggered by TiO~2~ NPs could be associated with the mitochondria and the signalling pathway. The authors suggest that TiO~2~ NPs contributed to a considerable increase in cytotoxicity to PC12 cells by inducing microglial activation.

In their works, the authors emphasise the potential effect of NPs on neurodegenerative diseases. Hu et al. \[[@CR90]\], using the example of embryos of zebrafish *(Danio rerio)* and PC12 cell cultures, investigated the neurotoxicity of titanium dioxide nanoparticles. They demonstrated that exposure to TiO~2~ NPs had an effect on the development of Parkinson's disease (PD). The results indicated that exposure to TiO~2~ NPs could lead to their accumulation in the brain of zebrafish larvae. An increase in the expression of genes (PINK1, parkin, α-*syn* and UCHL1) associated with the formation of Lewy bodies was observed. In addition, a loss of dopaminergic neurons could be noted, which is one of the characteristic features of PD. Researchers \[[@CR38]\] demonstrated that TiO~2~ NPs accumulated in the murine hippocampus, which led to apoptosis in the hippocampus and induced impairment of spatial memory in mice. Mohammadipour et al. \[[@CR91]\] found that after pregnant rats were administered TiO~2~ NPs (100 mg/kg bw), their offspring showed decreased proliferation of hippocampal cells and impaired spatial memory. Moreover, both the Morris water maze test and the passive avoidance test revealed that exposure to TiO~2~ NPs considerably distorted the inhibition and learning ability in the offspring. Jeon \[[@CR92]\], to enhance the understanding of the molecular mechanism at protein level, carried out a proteomic analysis of protein in the brain of mice. In 11 out of 990 analysed proteins, the level of expression changed more than twice after exposure to TiO~2~ NPs: eight proteins had higher and three lower expression after exposure to TiO~2~ NPs. Moreover, the activity of several antioxidative enzymes and acetylcholine esterase in the brain was reduced. A reduction in the activity of acetylcholine esterase can suggest an increase in cholinergic activity by raising the level of acetylcholine, which is significant for the treatment of Alzheimer's disease \[[@CR93]\]. Hu et al. \[[@CR94]\] in their studies also observed that the activity of acetylcholine esterase was inhibited after intragastric administration of TiO~2~ NPs to mice (over 60 days). In addition, they demonstrated a decrease in neurobehavioural and morphological capacity and brain damage symptoms in the Y maze test on mice. They also found inhibited activity of Na (^+^)/K (^+^) - ATPase, Ca (^2+^)-ATPase, Ca (^2+^)/Mg (^2+^) - ATPase, acetylcholine esterase, impaired function of the central cholinergic system, considerable reduction in the level of monoamine neurotransmitters (norepinephrine, dopamine and its metabolite 3,4-dihydroxyphenylacetic acid, 5-hydroxytryptamine and its metabolite 5-hydroxyindoleacetic acid) and an increased content of acetylcholine, glutamate and nitric oxide. Table [3](#Tab3){ref-type="table"} summarises the effect of TiO~2~ NPs exposure.Table 3The effect of exposure to NPsTiO~2~ on the nervous systemModelType NPsTiO~2~DoseExposure timeEffectReferencesMiceAnatase TiO~2~2.5, 5 and 10 mg/kg90 daysNeurogenic disease states in mice\[[@CR83]\]Mouse, microglia BV2Anatase TiO~2~2.5--120 ppm16 and 18 hProduce ROS and disturbed the production of mitochondrial energy\[[@CR84]\]Human U373 and rat C6 astrocytoma cell linesMixture of anatase and rutile20 mg/cm^2^2, 4, 6 and 24 hMorphological changes, damage to mitochondria and increased the mitochondrial membrane potential\[[@CR85]\]Lung tissue of ratsAnatase TiO~2~10 g/mg1 hDecrease in the mitochondrial membrane potential and the levels of NADH, production of ROS\[[@CR86]\]Human U373 and rat C6 astrocytoma cell linesMixture of anatase and rutile2.5, 5, 10, 20 and 40 g/cm^2^24, 48, 72 and 96 hToxic effect on glial cells by inducing their apoptosis\[[@CR33]\]Human brain lines SH-SY5Y and D384Anatase TiO~2~1.5--250 μg/ml 0.05--31 μg/ml4--24--48 h,7--10 daysMitochondrial brain lesions, membrane damage in the brain cells\[[@CR36]\]PC12 cells5, 50, 100 and 200 g/ml for anataseTiO~2~,200 g/ml for rutile TiO~2~25, 50, 100 and 200 l g/mL6 and 24 hApoptosis and inhibited cell cycle in PC12 cells\[[@CR87]\]Primary cultured hippocampal neuronsAnatase TiO~2~5, 15 or 30 μg /ml24 hIncreased release of lactate dehydrogenase, and apoptosis\[[@CR88]\]PC12 cellsUnknown0.25 and 0.5 mg/ml24 h (microglia) or 24 and 48 h (PC12 cells)Apoptosis of hippocampal neurons, increase in cytotoxicity to PC12 cells by inducing microglial activation\[[@CR89]\]Zebrafish (*Danio rerio*) embryos, PC12 cellsMixture of rutile and anatase0, 0.1, 1, 10 μg/mL24 hAccumulation TiO~2~ NPs in the brain of zebrafish larvae, an increase in the expression of genes (PINK1, parkin, α-syn and UCHL1), loss of dopaminergic neurons, which is one of the characteristic features of Parkinson's (PD)\[[@CR90]\]MiceAnatase TiO~2~5, 10 and 50 mg/kg60 daysAccumulation in the hippocampus, hippocampal apoptosis, induced impairment of spatial memory\[[@CR38]\]RatsAnatase TiO~2~100 mg/kg21 daysDecreased proliferation of hippocampal cells and impaired spatial memory\[[@CR91]\]MiceAnatase TiO~2~0.5, 10 and 50 mg/kg60 daysDecrease in neurobehavioural and morphological capacity and brain damage symptoms, impaired function of the central cholinergic system, considerable reduction in the level of monoamine neurotransmitters\[[@CR94]\]*ROS* reactive oxygen species, *NADH* nicotinamide adenine dinucleotide

Conclusions {#Sec11}
===========

Along with global economic growth, our direct or indirect exposure to metallic nanoparticles has been increasing. With regard to new properties offered by their small size, nanoparticles (NPs) are incorporated in more and more commercial products. Regular supply of TiO~2~ NPs at small doses can affect the intestinal mucosa, the brain, the heart and other internal organs, which can lead to an increased risk of developing many diseases, tumours or progress of existing cancer processes. The mechanism behind the nanotoxicity of NPs has not been discovered yet. Many studies attribute it to oxidative stress, thus nanotoxicity is still an important area for future exploration.
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